CVE-2026-56402 nanocoai CVE debrief

Who should care

NanoClaw users and administrators should assess exposure and verify their version of NanoClaw. They should also review and restrict access to the handleApprovalsResponse function, monitor for suspicious activity related to package installation, and plan vendor-supported updates or mitigations through normal change control where exposure is confirmed. Additionally, they should confirm whether affected product deployments exist in managed environments and a

Why it matters

CVE-2026-56402 is a high-severity privilege escalation vulnerability in NanoClaw before 2.1.17. Attackers with a valid questionId can exploit the handleApprovalsResponse function's lack of responder role authorization to approve or reject privileged actions like package installation. NanoClaw users and administrators should assess exposure, verify their version, and update to 2.1.17 or later if necessary.

• Potential privilege escalation for attackers with valid questionId
• Possible unauthorized package installation or modification
• Need for verification of NanoClaw version and update to 2.1.17 or later
• Importance of monitoring for suspicious activity related to package installation

Technical summary

The handleApprovalsResponse function in NanoClaw before 2.1.17 fails to verify responder role authorization, allowing attackers with a valid questionId to approve or reject privileged actions like package installation. This vulnerability has a high CVSS score of 7.1 and is classified as HIGH severity. The affected product is NanoClaw, and users should verify their version and update to 2.1.17 or later if necessary. The technical impact is a potential privilege escalation, and defenders should review and restrict access to the handleApprovalsResponse function.

Defensive priority

High priority for NanoClaw users to verify and update

Recommended defensive actions

• Verify NanoClaw version and update to 2.1.17 or later if necessary
• Review and restrict access to the handleApprovalsResponse function
• Monitor for suspicious activity related to package installation
• Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up
• Review the supplied official advisory or CVE record to validate affected scope, severity, and vendor guidance
• Plan vendor-supported updates or mitigations through normal change control where exposure is confirmed
• Check relevant monitoring, detection, and logs for exposed assets that need extra review

Evidence notes

CVE Program and NVD records indicate a privilege escalation vulnerability in NanoClaw before 2.1.17. The handleApprovalsResponse function fails to verify responder role authorization, allowing attackers with a valid questionId to approve or reject privileged actions.

Sources and references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.